Info

CsA

Neoral®

Tacro

Outcomes (n)a

(465)

(71)

(24)

Therapeutic abortions

8%

1.4%

0%

Spontaneous abortions

13%

17%

29%

Ectopic

0.7%

0%

0%

Stillborn

3%

1.4%

0%

Livebirths

75%

80%

71%

aincludes twins, triplets

CsA—Sandimmune® brand cyclosporine, Neoral®—Neoral® brand cyclosporine, tacro— Prograf™ (tacrolimus, FK506)

Table 21.5. NTPR: Newborn outcomes of female renal recipients
0 0

Post a comment